Abstract

Simple SummaryBlastocystis infection affects more than 1000 million people globally. Its frequency varies depending on sociodemographic conditions, hygienic habits, provision of public services, and predisposing factors for contracting the infection, considering the child population as the most affected in developing countries. The lack of studies on this protozoan prevents the understanding of its transmission dynamics and its implications for the population’s health. For this protozoan, the diagnosis is based on microscopic reporting by conventional techniques; and subtype identification, which vary depending on the epidemiological distribution, host, and symptoms. In our study, we describe its epidemiological and molecular characterization in a child population. Additionally, we compare the diagnosis methods of Blastocystis; our research identified a better sensitivity with molecular methods and a great diversity of alleles and subtypes in this population.Background: The present study aims to perform an epidemiological and molecular characterization of Blastocystis infection in a child population attending daycare centers of Medellín, Colombia. Methods: A total of 265 children aged 0–5 years were enrolled in five children’s centers in urban sectors of Medellín, northwestern Colombia. Stool samples were taken to identify intestinal parasites by direct examination, Ritchie–Frick concentration, and molecular identification of Blastocystis by conventional PCR and subtype (ST) identification by PCR barcoding with subsequent phylogenetic reconstruction. Kappa index was calculated to evaluate the agreement between microscopy and PCR for the diagnosis of Blastocystis. Results: The prevalence of intestinal protozoa was 36.6% (97/265), with Blastocystis as the most frequent parasitic protozoan at 15.8% (42/265), followed by Giardia intestinalis at 15.5% (41/265) and Endolimax nana at 15.1% (40/265). The prevalence of Blastocystis by PCR was 53.2% (141/265), the subtypes identified were ST3 at 30.5% (18/59), ST2 at 23.7% (14/59), ST1 at 20.3% (12/59), and with less frequency, ST4 at 5.1% (3/59), ST6 at 1.7% (1/59) and ST16 at 15.3% (9/59) allele 162. Conclusion: This study provides the first genetic characterization of Blastocystis subtypes circulating in a population of Medellín, Colombia, and also updates the epidemiology of Blastocystis subtypes in the world with the first identification of ST16 in humans.

Highlights

  • Blastocystis is one of the most frequently isolated intestinal eukaryotes in humans and some animals, such as poultry, dogs, rodents, pigs, reptiles, amphibians, and non-human primates, worldwide [1]

  • We found ST4 in a small proportion, which coincides with previous reports suggesting that this subtype is of recent origin in humans from the Americas [27] and in Colombia is found in animals such as monkeys (Alouatta spp.) and is associated with the enzootic cycle and in a small proportion in humans [8,15]

  • In a small proportion, ST6, and this subtype has been identified with greater frequency in humans in Europe, Africa, and Asia, and is associated with irritable bowel syndrome in patients infected only with Blastocystis [14,15]

Read more

Summary

Introduction

Blastocystis is one of the most frequently isolated intestinal eukaryotes in humans and some animals, such as poultry, dogs, rodents, pigs, reptiles, amphibians, and non-human primates, worldwide [1]. It is currently considered an intestinal protozoan of relevance in public health, as it infects more than a billion of people in the world, and its prevalence is higher in tropical and subtropical areas of developing countries [2,3]. The present study aims to perform an epidemiological and molecular characterization of Blastocystis infection in a child population attending daycare centers of Medellín, Colombia. The prevalence of Blastocystis by PCR was 53.2% (141/265), the subtypes identified were ST3 at 30.5% (18/59), ST2 at

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call